Trends in Prehospital Encounters for Youth Opioid Overdose Identified
Medically reviewed by Drugs.com.
By Elana Gotkine HealthDay Reporter
WEDNESDAY, Sept. 18, 2024 -- Prehospital encounters for youth opioid overdoses increased before the COVID-19 pandemic, then increased with onset, and then stabilized, according to a research letter published online Sept. 18 in the Journal of the American Medical Association.
Jamie K. Lim, M.D., from the Ann & Robert H. Lurie Children's Hospital of Chicago, and colleagues conducted a cross-sectional study of emergency medical services (EMS) encounters to identify prehospital encounters for youth opioid overdoses. An interrupted time series analysis was performed to examine trends before (January 2018 to February 2020) and during (April 2020 to December 2022) the COVID-19 pandemic.
The researchers identified 202,387,226 EMS encounters from 2018 through 2022; 91,743 youth opioid overdose encounters were analyzed. Most of these occurred among those aged 18 through 24 years (86.7 percent) and among males (65.1 percent). There was a significant increase seen in prepandemic EMS encounters with youth who overdosed on opioids, with 810 and 1,538 encounters in January 2018 and February 2020, respectively. The trend was mainly driven by overdoses in those aged 18 to 24 years. An immediate and significant increase in overdose encounters was seen in association with the pandemic interruption, followed by a change from significant increase to no significant change; the number of monthly encounters generally remained above prepandemic levels (1,824 and 1,503 encounters in April 2020 and December 2022, respectively). The trends were mainly due to those aged 18 to 24 years.
"Prehospital encounters for youth opioid overdoses were increasing prior to the pandemic, increased with the onset, and then stabilized, remaining higher than prepandemic levels," the authors write.
Abstract/Full Text (subscription or payment may be required)
Disclaimer: Statistical data in medical articles provide general trends and do not pertain to individuals. Individual factors can vary greatly. Always seek personalized medical advice for individual healthcare decisions.
Source: HealthDay
Posted : 2024-09-19 12:00
Read more
- Flu-Linked Hospitalization Rates Vary Across Seasons, Highest in Adults 65+
- Newborn Genome Analysis Spots More Health Issues Than Standard Screening
- Protega Pharmaceuticals Receives FDA Approval for RoxyBond (oxycodone hydrochloride) Immediate-Release 10 mg Tablet with Abuse-Deterrent Technology for Management of Pain
- Prenatal Cannabis Exposure May Impact Executive Function, Behavior at Age 5 Years
- Transcatheter Valve Replacement Best for Severe Tricuspid Regurgitation
- FDA Approves Vyalev (foscarbidopa and foslevodopa) for Adults Living with Advanced Parkinson's Disease
Disclaimer
Every effort has been made to ensure that the information provided by Drugslib.com is accurate, up-to-date, and complete, but no guarantee is made to that effect. Drug information contained herein may be time sensitive. Drugslib.com information has been compiled for use by healthcare practitioners and consumers in the United States and therefore Drugslib.com does not warrant that uses outside of the United States are appropriate, unless specifically indicated otherwise. Drugslib.com's drug information does not endorse drugs, diagnose patients or recommend therapy. Drugslib.com's drug information is an informational resource designed to assist licensed healthcare practitioners in caring for their patients and/or to serve consumers viewing this service as a supplement to, and not a substitute for, the expertise, skill, knowledge and judgment of healthcare practitioners.
The absence of a warning for a given drug or drug combination in no way should be construed to indicate that the drug or drug combination is safe, effective or appropriate for any given patient. Drugslib.com does not assume any responsibility for any aspect of healthcare administered with the aid of information Drugslib.com provides. The information contained herein is not intended to cover all possible uses, directions, precautions, warnings, drug interactions, allergic reactions, or adverse effects. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.
Popular Keywords
- metformin obat apa
- alahan panjang
- glimepiride obat apa
- takikardia adalah
- erau ernie
- pradiabetes
- besar88
- atrofi adalah
- kutu anjing
- trakeostomi
- mayzent pi
- enbrel auto injector not working
- enbrel interactions
- lenvima life expectancy
- leqvio pi
- what is lenvima
- lenvima pi
- empagliflozin-linagliptin
- encourage foundation for enbrel
- qulipta drug interactions